Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey

Documenti analoghi

• Cost‐Effectiveness of Treating Hepatitis C in Clients on Opioid Agonist Therapy in Community Pharmacies Compared to Primary Healthcare in Australia
  di: Joshua F. Ginnane, et al.
  Pubblicazione: (2024)
• A National Survey of Pharmacist Involvement in Hepatitis C Virus Management in the United States
  di: Michelle T. Martin, et al.
  Pubblicazione: (2024)
• Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial
  di: K. Heath, et al.
  Pubblicazione: (2025)
• Pharmacist‐Led Hepatitis C Diagnosis and Rapid Management—In Community ( PHARM ‐C): Results From a Phase IV Nonblinded Randomised Controlled Trial
  di: Mia J. Biondi, et al.
  Pubblicazione: (2025)
• Hepatitis Delta Coinfection Rates and All‐Cause Mortality Among Hepatitis B‐Infected Veterans in the USA
  di: Adeel A. Butt, et al.
  Pubblicazione: (2024)